The American Diabetes Association (ADA) has decided to lower the Body Mass Index (BMI) cut point at which it recommends screening Asian Americans for type 2 diabetes. This change in ADA guidelines is aligned with evidence that many Asian Americans develop the disease at lower BMI levels than the population at large, according to a position statement being published in the January issue of Diabetes Care.
The U.S. FDA has approved the Animas Vibe insulin pump and Continuous Glucose Monitoring (CGM) system for the management of insulin-requiring diabetes in adults ages 18 and older.
We’re thrilled to be teaming up with Le Creuset to celebrate Diabetes Awareness Month and promote home cooking. Enter this giveaway to…
Novo Nordisk and Roche Diabetes Care have launched NovoRapid PumpCart, the first prefilled pump cartridge with an insulin analogue that has been specifically designed for insulin pumps. This new treatment solution, which contains Novo Nordisk's rapid-acting insulin NovoRapid (insulin aspart) is expected to make insulin pump therapy...
ASweetLife is thrilled to be teaming up with Magimix by Robot-Coupe to promote home cooking during Diabetes Awareness Month.
As we all know,…
JDRF announced that JDRF-funded partner, ViaCyte, Inc. has for the first time ever implanted a person with type 1 diabetes with an experimental encapsulated cell therapy product candidate, called VC-01, which is being developed for the treatment of type 1 diabetes. This individual, and others to follow, is participating in a trial to evaluate the safety and efficacy of the VC-01 product candidate, a potential replacement source of insulin-producing cells.
The FDA has approved Dexcom's CGM remote mobile communications device: Dexcom SHARE. Dexcom SHARE, an accessory to the Dexcom G4 PLATINUM Continuous Glucose Monitoring System, uses a secure wireless connection to transmit the glucose levels of a person with diabetes to the smartphones
Medtronic has begun enrolling patients in an investigational device exemption (IDE) study of its new and innovative Predictive Low Glucose Management (PLGM) technology. The start of this study marks a critical step toward development of an artificial pancreas in the U.S. market.
On October 24-25th, 2014, hundreds of women with diabetes and their loved ones will descend upon the Embassy Suites LAX North for DiabetesSisters’ power-packed weekend conference. This will be the eighth Conference hosted by DiabetesSisters and the first time it will convene in the Los Angeles, CA area.
We are very excited to announce that the Marjorie t-shirt fundraiser sale kicks off today. Shirts will be available to purchase until October 17th.